Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 1,101–1,133 of 1,133
Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues
Alle, Q., Le Borgne, E., Milhavet, O., & Lemaitre, J.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083990 · Cited by 35
“The reprogramming protocol used has been optimized and is based on the use of a cocktail of the combined six reprogramming factors from pooling the overlapping four factor cocktails of Yamanaka [71] and Thomson [102], i.e., OCT4, SOX2, KLF4, C-MYC, NANOG, and LIN28 (OSKMNL).”
BackgroundMethodFinding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia
Müller, L. U. W., & Williams, D. A. (2009) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2009.03.010 · Cited by 31
In‐a‐dish: Induced pluripotent stem cells as a novel model for human diseases
Beltrão‐Braga, P. C. B., Pignatari, G. C., Russo, F. B., Fernandes, I. R., & Muotri, A. R. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22231 · Cited by 30
Mechanism and treatment strategy of osteoporosis after transplantation
Song, L., Xie, X.-B., Peng, L.-K., Yu, S.-J., & Peng, Y.-T. (2015) · International Journal of Endocrinology · doi:10.1155/2015/280164 · Cited by 30
“These induced pluripotent human stem cells were first successfully established from the human in 2007 [61].”
BackgroundWilson, H. K., Faubion, M. G., Hjortness, M. K., Palecek, S. P., & Shusta, E. V. (2016) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2016.0345 · Cited by 29
Genetics of Human Sleep Behavioral Phenotypes
Hsu, P.-K., Ptáček, L. J., & Fu, Y.-H. (2015) · Methods in Enzymology · doi:10.1016/bs.mie.2014.10.046 · Cited by 29
“urine samples (containing exfoliated renal epithelial cells; Takahashi et al., 2007; Yu et al., 2007; Zhou et al., 2012).”
BackgroundStem cell-based therapy for diseases of the retinal pigment epithelium: from bench to bedside
Sachdeva, M. M., & Eliott, D. (2016) · Seminars in Ophthalmology · doi:10.3109/08820538.2015.1115253 · Cited by 28
STAMP: Single-cell transcriptomics analysis and multimodal profiling through imaging
Pitino, E., Pascual-Reguant, A., Segato-Dezem, F., Wise, K., Salvador-Martinez, I., Crowell, H. L., Marção, M., Ruiz, M., Courtois, E., Flynn, W. F., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.027 · Cited by 28
“32,33 Hence, iPSCs have been used to drive discovery in applications such as disease modeling, 34,35 drug screening and toxicity testing, 36,37 regenerative medicine, 38,39 immune research, 40 and studying lineage specification.”
Building gut from scratch — progress and update of intestinal tissue engineering
Tullie, L., Jones, B. C., De Coppi, P., & Li, V. S. W. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00586-x · Cited by 27
“…cell biology were made, including derivation of pluripotent stem cells [G] (PSCs) from mouse and human embryos 47,48 , identification of factors required to induce pluripotency in somatic cells 49-51 and discovery of the actively dividing multipotent Lgr5 -positive ISCs [G] in adult intestine 31 .”
BackgroundSchaniel, C., Dhanan, P., Hu, B., Xiong, Y., Raghunandan, T., Gonzalez, D. M., Dariolli, R., D'Souza, S. L., Yadaw, A. S., Hansen, J., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.10.005 · Cited by 26
Moslem, M., Eberle, I., Weber, I., Henschler, R., & Cantz, T. (2015) · Stem Cells International · doi:10.1155/2015/843058 · Cited by 25
“One factor combination was comprised of Oct4, Sox2, Klf4, and c-Myc (OSKM) as it was originally described by Shinya Yamanaka and subsequently in multitudinous publications [8–10] and the other combination consisted of Oct4, Sox2, Nanog, and Lin28 (OSNL) as it was described by James Thomson and some further groups [7,…”
MethodChen, X., Sun, G., Feng, L., Tian, E., & Shi, Y. (2025) · Communications Biology · doi:10.1038/s42003-024-07401-0 · Cited by 23
“The combination of the human iPSC technology 38,39 with the brain organoid platform has allowed modeling of both human brain development and brain disorders 1,3,5 – 11, 40, 41 .”
Dey, C., Raina, K., Haridhasapavalan, K. K., Thool, M., Sundaravadivelu, P. K., Adhikari, P., Gogoi, R., & Thummer, R. P. (2021) · Recent Advances in iPSC Technology · doi:10.1016/b978-0-12-822231-7.00011-4 · Cited by 23
Peskova, L., Cerna, K., Oppelt, J., Mraz, M., & Barta, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-52294-3 · Cited by 23
Gong, J., Fields, M. A., Moreira, E. F., Bowrey, H. E., Gooz, M., Ablonczy, Z., & Del Priore, L. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143272 · Cited by 21
“Induced pluripotent stem cells (iPSCs) can be generated via the expression of OCT4, NANOG, Sox2 and Lin28 [17, 18], using lentiviral and retroviral methods.”
MethodZhang, Z., Xiang, D., & Wu, W.-S. (2014) · Cellular Reprogramming · doi:10.1089/cell.2013.0070 · Cited by 20
“iPSCs hold great potential in basic stem cell biology and regenerative medicine (Lowry et al., 2008; Meissner et al., 2007; Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007).”
BackgroundDevelopment of substrates for the culture of human pluripotent stem cells
Kawase, E., & Nakatsuji, N. (2023) · Biomaterials Science · doi:10.1039/d2bm01473d · Cited by 20
Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells
Charaf, L., Mahon, F.-X., Lamrissi-Garcia, I., Moranvillier, I., Beliveau, F., Cardinaud, B., Dabernat, S., de Verneuil, H., Moreau-Gaudry, F., & Bedel, A. (2017) · Leukemia · doi:10.1038/leu.2016.154 · Cited by 16
Ocular Fluid As a Replacement for Serum in Cell Cryopreservation Media
Varma, V. P., Devi, L., Venna, N. K., Murthy, C. L. N., Idris, M. M., & Goel, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131291 · Cited by 18
“Mouse embryonic fibroblast (MEF) cells are used as feeder cells to maintain ES cells and induced pluripotent stem (iPS) cells in the undifferentiated state [9, 10].”
BackgroundPons-Espinal, M., Blasco-Agell, L., & Consiglio, A. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03700-x · Cited by 18
Shin, J. W., Suzuki, T., Ninomiya, N., Kishima, M., Hasegawa, Y., Kubosaki, A., Yabukami, H., Hayashizaki, Y., & Suzuki, H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks732 · Cited by 12
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
BackgroundTelomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling
Ly, H. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i10.89 · Cited by 12
Cardiac differentiation roadmap for analysis of plasticity and balanced lineage commitment
Snabel, R. R., Cofiño-Fabrés, C., Baltissen, M., Schwach, V., Passier, R., & Veenstra, G. J. C. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102422 · Cited by 10
AP-1 activity is a major barrier of human somatic cell reprogramming
Liu, Y., He, J., Chen, R., Liu, H., Chen, J., Liu, Y., Wang, B., Guo, L., Pei, D., Wang, J., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03883-x · Cited by 10
Epidermal stem cells: an update on their potential in regenerative medicine
Sun, X., Fu, X., Han, W., Zhao, M., & Chalmers, L. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.776036 · Cited by 10
“As abovementioned, iPSCs can be derived from reprogramming somatic differentiated cells by the erasure of all developmentally acquired epigenetic information [55,57].”
BackgroundChen, K., Linares, I. M., Trempel, M. A., Feidler, A. M., De Silva, D., Farajollahi, S., Jones, J., Kuebel, J., Kasap, P., Engelhardt, B., et al. (2025) · Advanced Science · doi:10.1002/advs.202508271 · Cited by 9
Advances in Islet Transplantation and the Future of Stem Cell–Derived Islets to Treat Diabetes
Kieffer, T. J., Hoesli, C. A., & Shapiro, A. M. J. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041624 · Cited by 7
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Huang, C.-H., Tsai, J. J. P., Kurubanjerdjit, N., & Ng, K.-L. (2019) · doi:10.1101/536318 · Cited by 4
“It is well-known that with the LIN28 genes, these four genes are liable to reprogram human somatic cells into pluripotent stem cells 45 .”
BackgroundSingle‐cell pluripotency regulatory networks
Stumpf, P. S., Ewing, R., & MacArthur, B. D. (2016) · PROTEOMICS · doi:10.1002/pmic.201500528 · Cited by 4
MYCL promotes iPSC-like colony formation via MYC Box 0 and 2 domains
Akifuji, C., Iwasaki, M., Kawahara, Y., Sakurai, C., Cheng, Y.-S., Imai, T., & Nakagawa, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-03260-5 · Cited by 3
Arai, H., Millstein, J., Loupakis, F., Stintzing, S., Wang, J., Battaglin, F., Kawanishi, N., Jayachandran, P., Soni, S., Zhang, W., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.03.048 · Cited by 2
CauTrigger: deciphering biological system state transitions by hierarchical causal decomposition
Zhang, C., Cai, D., Aihara, K., & Chen, L. (2026) · Nature Methods · doi:10.1038/s41592-026-03274-9
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.